Matthieu Drouyer

503 total citations
15 papers, 322 citations indexed

About

Matthieu Drouyer is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Matthieu Drouyer has authored 15 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Genetics and 6 papers in Neurology. Recurrent topics in Matthieu Drouyer's work include Virus-based gene therapy research (8 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and CRISPR and Genetic Engineering (4 papers). Matthieu Drouyer is often cited by papers focused on Virus-based gene therapy research (8 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and CRISPR and Genetic Engineering (4 papers). Matthieu Drouyer collaborates with scholars based in Australia, Poland and France. Matthieu Drouyer's co-authors include Jean‐Marc Taymans, Marie‐Christine Chartier‐Harlin, Leszek Lisowski, Erhua Zhu, Ian E. Alexander, Marti Cabanes‐Creus, Adrian Westhaus, Suzanne Scott, Adrian J. Thrasher and Giorgia Santilli and has published in prestigious journals such as Scientific Reports, Human Molecular Genetics and Science Translational Medicine.

In The Last Decade

Matthieu Drouyer

15 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthieu Drouyer Australia	9	210	155	96	44	34	15	322
Hayley Goullée Australia	9	123 0.6×	39 0.3×	52 0.5×	26 0.6×	26 0.8×	17	230
Junqiang Ye United States	10	344 1.6×	46 0.3×	106 1.1×	30 0.7×	92 2.7×	17	554
Michèle G. DuVal Canada	11	236 1.1×	118 0.8×	45 0.5×	105 2.4×	128 3.8×	18	476
Brian Lin United States	9	163 0.8×	62 0.4×	23 0.2×	17 0.4×	34 1.0×	16	256
Naoki Kurihara Japan	8	200 1.0×	46 0.3×	52 0.5×	29 0.7×	181 5.3×	9	486
Julie Smith United States	4	301 1.4×	71 0.5×	29 0.3×	33 0.8×	30 0.9×	4	478
Oana Palasca Denmark	6	209 1.0×	56 0.4×	28 0.3×	9 0.2×	18 0.5×	11	340
Mengmeng Shi China	10	99 0.5×	81 0.5×	90 0.9×	44 1.0×	22 0.6×	20	289
Nirmal Vadgama United Kingdom	7	84 0.4×	35 0.2×	16 0.2×	35 0.8×	36 1.1×	13	168
Dominika Fričová Slovakia	7	161 0.8×	18 0.1×	41 0.4×	22 0.5×	32 0.9×	8	260

Countries citing papers authored by Matthieu Drouyer

Since Specialization

Citations

This map shows the geographic impact of Matthieu Drouyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Drouyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Drouyer more than expected).

Fields of papers citing papers by Matthieu Drouyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthieu Drouyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Drouyer. The network helps show where Matthieu Drouyer may publish in the future.

Co-authorship network of co-authors of Matthieu Drouyer

This figure shows the co-authorship network connecting the top 25 collaborators of Matthieu Drouyer. A scholar is included among the top collaborators of Matthieu Drouyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthieu Drouyer. Matthieu Drouyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Drouyer, Matthieu, Adrian Westhaus, Suzanne Scott, et al.. (2024). Enhanced AAV transduction across preclinical CNS models: A comparative study in human brain organoids with cross-species evaluations. Molecular Therapy — Nucleic Acids. 35(3). 102264–102264. 4 indexed citations

Drouyer, Matthieu, Tak‐Ho Chu, Elodie Labit, et al.. (2024). Novel AAV variants with improved tropism for human Schwann cells. Molecular Therapy — Methods & Clinical Development. 32(2). 101234–101234. 5 indexed citations

Drouyer, Matthieu, Suzanne Scott, Sophia H.Y. Liao, et al.. (2024). Development of CNS tropic AAV1-like variants with reduced liver-targeting following systemic administration in mice. Molecular Therapy. 32(3). 818–836. 8 indexed citations

Iannotta, Lucia, Marco Emanuele, Antonio Jesús Lara Ordóñez, et al.. (2023). PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formation. Frontiers in Molecular Neuroscience. 16. 1269387–1269387. 3 indexed citations

Athanasopoulos, Panagiotis S., Romain Magnez, Matthieu Drouyer, et al.. (2022). A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively. Cells. 11(6). 1018–1018. 5 indexed citations

Cabanes‐Creus, Marti, Erhua Zhu, Sophia H.Y. Liao, et al.. (2021). Novel human liver-tropic AAV variants define transferable domains that markedly enhance the human tropism of AAV7 and AAV8. Molecular Therapy — Methods & Clinical Development. 24. 88–101. 24 indexed citations

Cabanes‐Creus, Marti, Sophia H.Y. Liao, Matthieu Drouyer, et al.. (2021). Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsids. Molecular Therapy — Methods & Clinical Development. 21. 607–620. 16 indexed citations

Drouyer, Matthieu, Marc Bolliger, Evy Lobbestael, et al.. (2021). Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation. Neurobiology of Disease. 157. 105426–105426. 9 indexed citations

Cabanes‐Creus, Marti, Claus V. Hallwirth, Adrian Westhaus, et al.. (2020). Restoring the natural tropism of AAV2 vectors for human liver. Science Translational Medicine. 12(560). 33 indexed citations

10.

Westhaus, Adrian, Marti Cabanes‐Creus, Erhua Zhu, et al.. (2020). High-Throughput In Vitro , Ex Vivo, and In Vivo Screen of Adeno-Associated Virus Vectors Based on Physical and Functional Transduction. Human Gene Therapy. 31(9-10). 575–589. 69 indexed citations

11.

Cabanes‐Creus, Marti, Adrian Westhaus, Erhua Zhu, et al.. (2020). Attenuation of Heparan Sulfate Proteoglycan Binding Enhances In Vivo Transduction of Human Primary Hepatocytes with AAV2. Molecular Therapy — Methods & Clinical Development. 17. 1139–1154. 31 indexed citations

12.

Drouyer, Matthieu, et al.. (2020). LRRK2 Phosphorylation, More Than an Epiphenomenon. Frontiers in Neuroscience. 14. 527–527. 41 indexed citations

13.

Bétemps, Dominique, Matthieu Drouyer, Jérémy Verchère, et al.. (2018). Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy. Scientific Reports. 8(1). 17563–17563. 4 indexed citations

14.

Ramírez, Marian Blanca, Antonio Jesús Lara Ordóñez, Elena Fdez, et al.. (2017). GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2. Human Molecular Genetics. 26(14). 2747–2767. 58 indexed citations

15.

Taymans, Jean‐Marc, et al.. (2017). LRRK2 detection in human biofluids: potential use as a Parkinson's disease biomarker?. Biochemical Society Transactions. 45(1). 207–212. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact